Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia

被引:68
作者
Newell, Kelly A.
Zavitsanou, Katerina
Jew, Stephen Kum
Huang, Xu-Feng
机构
[1] Univ Wollongong, Dept Biomed Sci, Wollongong, NSW 2522, Australia
[2] Univ Sydney, Tissue Resource Ctr, Dept Pathol, Sydney, NSW 2006, Australia
关键词
human brain; H-3]muscimol; H-3]pirenzepine; posterior cingulate cortex; schizophrenia; receptor density;
D O I
10.1016/j.pnpbp.2006.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The posterior cingulate cortex (PCC), a key component of the limbic system, has been implicated in the pathology of schizophrenia because of its sensitivity to NMDA receptor antagonists. Recent studies have shown that the PCC is dysfunctional in schizophrenia, and it is now suspected to be critically involved in the pathogenesis of schizophrenia. Studies also suggest that there are abnormalities in muscarinic and GABAergic neurotransmission in schizophrenia. Therefore, in the present study we used quantitative autoradiography to investigate the binding of [H-3] pirenzepine, [H-3]AF-DX 384 and [H-3] muscimol, which respectively label M1/4 and M2/4 muscarinic and GABA(A) receptors, in the PCC of schizophrenia and control subjects matched for age and post-mortem interval. The present study found that [H-3]pirenzepine binding was significantly decreased in the superficial (-24%, p = 0.002) and deep (-35%, p < 0.001) layers of the PCC in the schizophrenia group as compared with the control group. In contrast, a dramatic increase in [H-3]muscimol binding was observed in the superficial (+ 112%, p=0.001) and deep layers (+ 100%, p = 0.017) of the PCC in the schizophrenia group. No difference was observed for [H-3]AF-DX 384 binding between the schizophrenia and control groups. The authors found a significant inverse correlation between [H-3]pirenzepine binding in the deep cortical layers and [H-3]muscimol binding in the superficial layers (rho = -0.732, p=0.003). In addition, negative correlations were also found between age and [H-3]pirenzepine binding in both superficial and deep cortical layers (rho=-0.669 p=0.049 and rho=-0.778, p=0.014), and between age of schizophrenia onset and [H-3]AF-DX 384 binding (rho=-0.798,p=0.018). These results for the first time demonstrated the status of M1/M4, M2/M4 and GABA(A) receptors in the PCC in schizophrenia. whilst the exact mechanism causing these alterations is not yet known, a possible increased acetylcholine and down regulated GABA stimulation in the PCC of schizophrenia is suggested. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 54 条
  • [31] LOSS OF M2 MUSCARINE RECEPTORS IN THE CEREBRAL-CORTEX IN ALZHEIMERS-DISEASE AND EXPERIMENTAL CHOLINERGIC DENERVATION
    MASH, DC
    FLYNN, DD
    POTTER, LT
    [J]. SCIENCE, 1985, 228 (4703) : 1115 - 1117
  • [32] Volume of the cingulate and outcome in schizophrenia
    Mitelman, SA
    Shihabuddin, L
    Brickman, AM
    Hazlett, EA
    Buchsbaum, MS
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 72 (2-3) : 91 - 108
  • [33] Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release
    Moore, H
    Fadel, J
    Sarter, M
    Bruno, JP
    [J]. NEUROSCIENCE, 1999, 88 (03) : 811 - 822
  • [34] Ionotropic glutamate receptor binding in the posterior cingulate cortex in schizophrenia patients
    Newell, KA
    Zavitsanou, K
    Huang, XF
    [J]. NEUROREPORT, 2005, 16 (12) : 1363 - 1367
  • [35] OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998
  • [36] NMDA ANTAGONIST NEUROTOXICITY - MECHANISM AND PREVENTION
    OLNEY, JW
    LABRUYERE, J
    WANG, G
    WOZNIAK, DF
    PRICE, MT
    SESMA, MA
    [J]. SCIENCE, 1991, 254 (5037) : 1515 - 1518
  • [37] PERRY TL, 1979, LANCET, V1, P237
  • [38] Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain
    Piggott, M
    Owens, J
    O'Brien, J
    Paling, S
    Wyper, D
    Fenwick, J
    Johnson, M
    Perry, R
    Perry, E
    [J]. JOURNAL OF CHEMICAL NEUROANATOMY, 2002, 24 (03) : 211 - 223
  • [39] Central muscarinic acetylcholine receptor availability in patients treated with clozapine
    Raedler, TJ
    Knable, MB
    Jones, DW
    Urbina, RA
    Egan, MF
    Weinberger, DR
    [J]. NEUROPSYCHOPHARMACOLOGY, 2003, 28 (08) : 1531 - 1537
  • [40] In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia
    Raedler, TJ
    Knable, MB
    Jones, DW
    Lafargue, T
    Urbina, RA
    Egan, MF
    Pickar, D
    Weinberger, DR
    [J]. NEUROPSYCHOPHARMACOLOGY, 2000, 23 (01) : 56 - 68